A Single-Center Clinical Study to Evaluate Shenxiong Glucose Injection Combined with Edaravone in the Treatment of Acute Large-Area Cerebral Infarction
Table 1
Comparison of general information of the two groups of patients.
Item
Experimental group ()
Control group ()
Age (years)
0.15
Sex (M/F)
40/38
41/37
0.52
Smoke (, %)
28 (35.89%)
30 (38.46%)
0.48
Hypertension (, %)
18 (23.07%)
21 (26.92%)
0.39
Diabetes (, %)
11 (14.10%)
12 (15.38%)
0.62
SCr (μmol/l)
0.67
UA (μmol/l)
0.29
TC (mmol/l)
0.23
TG (mmol/l)
0.48
HDL-C (mmol/l)
0.78
LDL-C (mmol/l)
0.88
AST/ALT
0.77
BMI (kg/m2)
0.26
Coronary heart disease
12 (15.38)
13 (16.67)
0.64
Atrial fibrillation
8 (10.25)
9 (11.53)
0.62
BMI: body mass index; TG: triglyceride; TC: total cholestrol; HDL-C: high density lipoprotein-cholestrol; LDL-C: low high density lipoprotein-cholestrol.
